Clover Health
| Company type | Public |
|---|---|
| Industry | Healthcare |
| Founded | 2014 |
| Founder | Vivek Garipalli, Kris Gale |
| Headquarters | Franklin, Tennessee , United States |
Area served | Arizona, Georgia, Kansas, New Jersey, New York, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Vermont |
Key people | Andrew Toy (CEO), Vivek Garipalli (Executive Chairman) |
| Products | Medicare Advantage insurance plans, care management services |
Clover Health Investments, Corp. is an American healthcare organization established in 2014 that offers Medicare Advantage (MA) insurance plans and functions as a direct contracting entity with the U.S. government. It provides care management services for Medicare recipients in 11 states and commenced public trading on January 8, 2021.
History
Founded in 2014 by Vivek Garipalli and Kris Gale, Garipalli had earlier launched CarePoint Health, a hospital network based in New Jersey. By 2015, Clover covered over 7,200 individuals and expanded its membership to more than 39,000 by 2019, generating $427.4 million in revenue while reporting a net loss of $60.57 million.
In 2016, the company was penalized $106,095 due to deceptive marketing regarding care locations; following payment of the fine, Clover revised its promotional content. Gale exited the company in 2017. That same year, Clover initiated a home-based primary care program targeting homebound members and broadened this initiative through partnerships in 2021 aimed at lowering costs and reducing hospital admissions.
In 2018, Clover collaborated with MindMate to introduce cognitive games designed for senior adults. The next year saw the launch of Clover Therapeutics, a biopharmaceutical division leveraging member data to create treatments for chronic age-related illnesses, including a partnership with Genentech focused on genetic research related to ocular diseases. In 2019, Clover realigned its strategy toward healthcare expertise and cut its workforce by roughly 20%.
In February 2021, short seller Hindenburg Research accused Clover of failing to disclose a Department of Justice investigation prior to its IPO, which triggered a 12% decline in stock price. Clover responded by stating that the inquiry was immaterial according to legal counsel. Subsequently, the SEC initiated its own investigation. By April 2021, Clover commenced direct contracting with CMS to negotiate fees with physicians under fee-for-service Medicare; approximately half of its beneficiaries were enrolled through this method. In June, Clover became classified as a “meme stock,” experiencing significant price fluctuations fueled by Reddit investors; shares surged 20% following the company’s warning about risks related to short squeezes.
In 2023, Andrew Toy took over as CEO while Garipalli continued serving as executive chairman.
Funding and IPO
From 2015 through 2017, Clover Health raised multiple venture capital rounds from firms such as First Round Capital, Sequoia Capital, and Greenoaks Capital. A Series D financing round in 2017 that included Alphabet Inc.’s GV valued the company at over $1.2 billion, earning it "unicorn" status.
In October 2020, Clover Health revealed a $3.7 billion plan to go public via a merger with a special-purpose acquisition company led by Chamath Palihapitiya. Trading on NASDAQ under the symbol CLOV began on January 8, 2021, with the company closing its debut day at an estimated market capitalization near $7 billion.
Short Seller Report and "Meme Stock" Phenomenon
Shortly after its IPO, Clover Health was targeted by Hindenburg Research’s critical report that caused shares to fall by approximately 15%. The firm then disclosed an ongoing SEC probe. Later in 2021, due to elevated short interest levels, Clover Health became categorized as a meme stock and experienced sharp price increases before retreating; as of June 2022, its share price remains significantly below the initial offering level.
Services
Clover Health specializes in providing Medicare Advantage plans, with a focus on rural and underserved communities. Under the leadership of CEO Andrew Toy, the organization supported 129,000 beneficiaries by August 2021 through its Medicare Advantage and direct contracting initiatives. Its service area includes 11 states: Arizona, Georgia, Kansas, New Jersey, New York, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, and Vermont.
The company created the Clover Assistant, an advanced machine learning platform designed to offer care guidance to primary care providers and notify them of clinical events such as medication pickups. This system consolidates health information to generate practical insights aimed at enhancing patient care outcomes.
Operations
Clover Health's main headquarters is located in Franklin, Tennessee, complemented by additional offices situated in San Francisco, California, Jersey City, New Jersey, and Hong Kong.
Among the members of Clover Health's board are Chelsea Clinton and Demetrios L. Kouzoukas, who formerly served as Director of the Center for Medicare and Principal Deputy Administrator at the Center for Medicare and Medicaid Services (CMS) during the Trump administration. Their involvement bolsters the company’s strategic emphasis on Medicare services and healthcare innovation.